BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7080591)

  • 1. [Aromatic retinoid (Ro-10) in the treatment of palmoplantar psoriasis pustulosa (author's transl)].
    Deichmann B; Spindeldreier A
    Z Hautkr; 1982 Mar; 57(6):425-8. PubMed ID: 7080591
    [No Abstract]   [Full Text] [Related]  

  • 2. Generalization of palmoplantar pustulosis after withdrawal of etretinate.
    Miyagawa S; Muramatsu T; Shirai T
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):305-6. PubMed ID: 2007689
    [No Abstract]   [Full Text] [Related]  

  • 3. [Side effects of oral retinoid Ro 10-9359 on the unaffected skin of psoriatic patients: retinoid dermatitis].
    Rüst O; Tufli T
    Schweiz Med Wochenschr; 1979 Dec; 109(48):1921-5. PubMed ID: 161414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of a systemically administered aromatic retinoid (Ro 10-9359) on the light sensitivity.
    Ippen H; Hofbauer M; Schauder S
    Derm Beruf Umwelt; 1978; 26(3):88-90. PubMed ID: 754925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral retinoid for psoriasis. A report of a double blind study.
    Pettit JH
    Acta Derm Venereol Suppl (Stockh); 1979; 59(85):133-6. PubMed ID: 393035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose etretinate in the maintenance of remission of palmoplantar pustular psoriasis.
    White SI; Puttick L; Marks JM
    Br J Dermatol; 1986 Nov; 115(5):577-82. PubMed ID: 3539171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acitretin and etretinate in the treatment of palmoplantar pustulosis: a double-blind comparative trial.
    Lassus A; Geiger JM
    Br J Dermatol; 1988 Dec; 119(6):755-9. PubMed ID: 2974306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroral aromatic retinoid treatment of palmoplantar pustulosis: double-blind comparison of Ro 10-9359 and placebo.
    Jansén C; Hollmén A; Pajarre R
    Acta Derm Venereol; 1979; 59(3):271-3. PubMed ID: 87093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etretinate in pustular psoriasis of palms and soles.
    White SI; Marks JM; Shuster S
    Br J Dermatol; 1985 Nov; 113(5):581-5. PubMed ID: 3904810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of pustular psoriasis with a new aromatic retinoid (RO 10-9359). Report on 9 generalized and 8 localized cases (author's transl)].
    Orfanos CE; Landes E; Bloch PH
    Ann Dermatol Venereol; 1978 Oct; 105(10):807-11. PubMed ID: 747292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral treatment of severe psoriasis with a new aromatic retinoid (Ro 10-9359) (author's transl)].
    Guilhou JJ; Malbos S; Meynadier J
    Ann Dermatol Venereol; 1978 Oct; 105(10):813-8. PubMed ID: 747293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acitretin in the treatment of severe psoriasis: a randomized double-blind study comparing acitretin and etretinate.
    Meffert H; Sönnichsen N
    Acta Derm Venereol Suppl (Stockh); 1989; 146():176-7. PubMed ID: 2532846
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combination aromatic retinoid-PUVA-therapy in the treatment of psoriatic arthritis. Preliminary study].
    Thivolet J; Robart S; Vignon E
    Ann Dermatol Venereol; 1979 Dec; 106(12):1037-8. PubMed ID: 533103
    [No Abstract]   [Full Text] [Related]  

  • 14. [Oral psoriasis treatment with a new aromatic retinoid (Ro 10-9359): a multi-centre controlled study of 291 patients (preliminary results) (author's transl)].
    Orfanos CE; Goerz G
    Dtsch Med Wochenschr; 1978 Feb; 103(5):195-9. PubMed ID: 631039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipid changes during acitretin (etretin) treatment of psoriasis and palmo-plantar pustulosis.
    Vahlquist C; Selinus I; Vessby B
    Acta Derm Venereol; 1988; 68(4):300-5. PubMed ID: 2459874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retinoid therapy].
    Fredriksson T
    Lakartidningen; 1979 Oct; 76(43):3771-2. PubMed ID: 529929
    [No Abstract]   [Full Text] [Related]  

  • 17. Tigason (etretinate) treatment in psoriatic arthritis.
    Ciompi ML; Bazzichi L; Marotta G; Pasero G
    Int J Tissue React; 1988; 10(1):25-7. PubMed ID: 3397251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palmoplantar eruption associated with etretinate therapy.
    David M; Ginzburg A; Hodak E; Feuerman EJ
    Acta Derm Venereol; 1986; 66(1):87-9. PubMed ID: 2424229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Etretinate: pro and con. Risk-benefit analysis of systemic retinoid therapy in psoriasis and recent developments: free aromatic acid, arotinoids].
    Gollnick H; Orfanos CE
    Hautarzt; 1985 Jan; 36(1):2-9. PubMed ID: 3156105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-epidermal accumulation of polymorphonuclear leukocytes in persistent palmoplantar pustulosis during treatment with acitretin.
    van de Kerkhof PC; Chang A; van Dooren-Greebe R; Geiger JM; Happle R
    Acta Derm Venereol; 1988; 68(6):499-503. PubMed ID: 2467488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.